Henan Guoshu Biotechnology

Henan Guoshu Biotechnology is a Chinese biotechnology company specializing in the development of next-generation gene editing technologies. Based in Zhengzhou, the company focuses on translating CRISPR-based research into therapeutic applications for genetic disorders and chronic diseases. Their core expertise lies in high-precision genome editing tools, including base editing and prime editing systems designed to minimize off-target effects. Guoshu Biotech aims to establish a robust pipeline of gene therapies targeting unmet medical needs in the Chinese and global markets. The company was founded by Dr. Yang Hui, a prominent scientist in the field of genome surgery and CRISPR technology.